1. Home
  2. GTY vs BEAM Comparison

GTY vs BEAM Comparison

Compare GTY & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTY
  • BEAM
  • Stock Information
  • Founded
  • GTY 1955
  • BEAM 2017
  • Country
  • GTY United States
  • BEAM United States
  • Employees
  • GTY N/A
  • BEAM N/A
  • Industry
  • GTY Real Estate
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GTY Finance
  • BEAM Health Care
  • Exchange
  • GTY Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • GTY 1.6B
  • BEAM 1.7B
  • IPO Year
  • GTY N/A
  • BEAM 2020
  • Fundamental
  • Price
  • GTY $27.74
  • BEAM $22.91
  • Analyst Decision
  • GTY Buy
  • BEAM Strong Buy
  • Analyst Count
  • GTY 6
  • BEAM 10
  • Target Price
  • GTY $32.67
  • BEAM $49.78
  • AVG Volume (30 Days)
  • GTY 279.1K
  • BEAM 2.8M
  • Earning Date
  • GTY 10-22-2025
  • BEAM 11-04-2025
  • Dividend Yield
  • GTY 6.77%
  • BEAM N/A
  • EPS Growth
  • GTY N/A
  • BEAM N/A
  • EPS
  • GTY 1.15
  • BEAM N/A
  • Revenue
  • GTY $210,071,000.00
  • BEAM $60,272,000.00
  • Revenue This Year
  • GTY $4.69
  • BEAM N/A
  • Revenue Next Year
  • GTY $7.66
  • BEAM $18.20
  • P/E Ratio
  • GTY $24.18
  • BEAM N/A
  • Revenue Growth
  • GTY 6.62
  • BEAM N/A
  • 52 Week Low
  • GTY $26.42
  • BEAM $13.53
  • 52 Week High
  • GTY $33.85
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • GTY 40.46
  • BEAM 55.46
  • Support Level
  • GTY $28.02
  • BEAM N/A
  • Resistance Level
  • GTY $28.73
  • BEAM $21.59
  • Average True Range (ATR)
  • GTY 0.36
  • BEAM 1.33
  • MACD
  • GTY -0.09
  • BEAM -0.23
  • Stochastic Oscillator
  • GTY 4.12
  • BEAM 98.79

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: